Tag: Guinea-Bissau
-
Backed Vaccination Study Begins in Guinea: Delaying Hepatitis B for Newborns
Overview of the Trial A new, government-funded clinical study began this week in Guinea-Bissau, focused on the timing of hepatitis B vaccination for newborns. The project, supported by funding from the United States Centers for Disease Control and Prevention (CDC), aims to delay the initial hepatitis B vaccine dose for some infants so researchers can…
-
Backed Vaccination Study Begins In Guinea
Overview A new, government-supported study has kicked off in Guinea-Bissau to investigate the optimal timing for administering hepatitis B vaccines to newborns. Funded by a U.S. government agency and coordinated with local health authorities, the trial could delay vaccination for up to about 7,000 newborns while researchers monitor outcomes. The study aims to determine whether…
-
Guinea-Bissau Hepatitis B Vaccination Timing Study Begins
Overview of the Guinea-Bissau Vaccination Timing Study A US government-funded study has begun in Guinea-Bissau to examine whether delaying the first hepatitis B vaccination for newborns could influence health outcomes. The trial, which involves up to 7,000 newborns, seeks to compare different vaccination timing strategies and assess any differences in infection rates, immune response, and…
-
Hepatitis B Vaccine Contract Sparks Ethics Concerns in Guinea-Bissau
Overview of the Contract The Trump administration has reportedly awarded a $1.6 million, no-bid contract to a Danish university to study hepatitis B vaccinations in newborns in Africa. Reports indicate the project focuses on administering Hepatitis B vaccines to infants in Guinea-Bissau, a West African country, with researchers hoping to gather data on safety, efficacy,…
-
Trump Admin Awards Hepatitis B Vaccine Contract to Europeans in Guinea-Bissau
Overview of the Controversial Award The Trump administration has awarded a $1.6 million, no-bid contract tied to a hepatitis B vaccination project involving newborns in Africa. The grant went to a Danish university, raising questions about procurement practices, ethics, and the role of foreign researchers in public health initiatives abroad. While supporters say the project…
-
Controversy Over $1.6 Million Hepatitis B Vaccination Study Contract Awarded to Danish University
Overview of the Contract A new $1.6 million contract has sparked debate after it was awarded without bidding to a Danish university to study the administration of hepatitis B vaccines to newborns in Africa. The arrangement, reportedly overseen by a unit within the U.S. administration, has drawn attention from ethics scholars, public health experts, and…
-
Guinea-Bissau Presidential Race: Both Leader Candidates Claim Victory as Results Await
The presidential race in Guinea-Bissau has entered a tense phase as both the incumbent and the main challenger publicly claim victory, even though the national electoral commission has not yet released official results. The competing narratives reflect a deeply polarized political landscape in a country where the outcome of the vote will shape the direction…
-
Guinea-Bissau Presidential Race: Incumbent and Challenger Claim Victory as Official Results Awaited
Overview: A Nation on Edge as Campaign Claims Hit the Airwaves Guinea-Bissau entered a tense post-election period as the country awaited official results from the presidential race. In a vote that drew international attention for its complexity and regional significance, both the incumbent president, Umaro Sissoco Embaló, and the main challenger, Fernando Dias, publicly claimed…
-
Guinea-Bissau Presidential Race: Victory Claims by Incumbent
Overview: A Delicate Walk Toward Official Results In Guinea-Bissau, the presidential election has entered a charged phase as the two leading candidates publicly declare victory even as the electoral commission continues to tally votes. The situation underscores a broader pattern seen in competitive races across West Africa, where preliminary assertions by campaign camps can collide…
-
Can Ivermectin Stop Malaria Transmission? What Trials Show
Can an ivermectin pill curb malaria transmission? The idea of using an ivermectin pill to curb malaria transmission is drawing renewed attention. Ivermectin, long used to treat parasitic worms and mass-administered for other diseases, can make the blood of treated people lethal to mosquitoes that bite them. The question researchers are asking is whether large‑scale…